Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 19, 2014, 116 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $270.00 to $10,493,197.62.

Highlighted Stocks Traded by Insiders:

RCS Capital (RCAP) - FREE Research Report

Nygaard Brian L, who is Chief Operating Officer at RCS Capital, bought 3,800 shares at $13.00 on Nov. 19, 2014. Following this transaction, the Chief Operating Officer owned 3,800 shares meaning that the stake was boosted by 100% with the 3,800-share transaction.

Jones Brian D, who is CFO & Ass. Secretary at RCS Capital, bought 9,000 shares at $13.05 on Nov. 19, 2014. Following this transaction, the CFO & Ass. Secretary owned 11,000 shares meaning that the stake was boosted by 450% with the 9,000-share transaction.

The shares most recently traded at $11.89, down $1.16, or 9.74% since the insider transaction. Historical insider transactions for RCS Capital go as follows:

  • 4-Week # shares bought: 20,550
  • 4-Week # shares sold: 5.0 million
  • 12-Week # shares bought: 21,550
  • 12-Week # shares sold: 5.0 million
  • 24-Week # shares bought: 27,007
  • 24-Week # shares sold: 5.0 million

The average volume for RCS Capital has been 1.2 million shares per day over the past 30 days. RCS Capital has a market cap of $861.4 million and is part of the financial sector and financial services industry. Shares are down 35.15% year-to-date as of the close of trading on Wednesday.

RCS Capital Corporation, through its subsidiaries, is engaged in the wholesale broker-dealer, and investment banking and capital markets business activities. The stock currently has a dividend yield of 3.01%. Currently, there are no analysts who rate RCS Capital a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on RCAP - FREE

TheStreet Quant Ratings rates RCS Capital as a sell. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, poor profit margins and generally disappointing historical performance in the stock itself. Get the full RCS Capital Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Masonite International (DOOR) - FREE Research Report

Lynch Frederick J, who is President and CEO at Masonite International, sold 2,000 shares at $54.48 on Nov. 19, 2014. Following this transaction, the President and CEO owned 242,151 shares meaning that the stake was reduced by 0.82% with the 2,000-share transaction.

The shares most recently traded at $55.53, up $1.05, or 1.89% since the insider transaction.

The average volume for Masonite International has been 233,100 shares per day over the past 30 days. Masonite International has a market cap of $1.6 billion and is part of the industrial goods sector and materials & construction industry. Shares are down 9.13% year-to-date as of the close of trading on Wednesday.

Masonite International Corporation designs, manufactures, and sells interior and exterior doors for the residential new construction; the residential repair, renovation, and remodeling; and the non-residential building construction markets worldwide. Currently, there are 4 analysts who rate Masonite International a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DOOR - FREE

TheStreet Quant Ratings rates Masonite International as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and disappointing return on equity. Get the full Masonite International Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

American Equity Investment Life (AEL) - FREE Research Report

Lorenzen Jeffrey D, who is Sr. Vice President-Investments at American Equity Investment Life, sold 1,900 shares at $27.04 on Nov. 19, 2014. Following this transaction, the Sr. Vice President-Investments owned 28,967 shares meaning that the stake was reduced by 6.16% with the 1,900-share transaction.

The shares most recently traded at $26.92, down $0.12, or 0.45% since the insider transaction. Historical insider transactions for American Equity Investment Life go as follows:

  • 4-Week # shares sold: 5,000
  • 12-Week # shares sold: 5,000
  • 24-Week # shares sold: 5,000

The average volume for American Equity Investment Life has been 606,400 shares per day over the past 30 days. American Equity Investment Life has a market cap of $2.0 billion and is part of the financial sector and insurance industry. Shares are up 1.93% year-to-date as of the close of trading on Wednesday.

American Equity Investment Life Holding Company, through its subsidiaries, operates in the insurance business in 50 states and the District of Columbia. It underwrites fixed annuities, including fixed index annuities and fixed rate annuities, as well as single premium immediate annuities. The stock currently has a dividend yield of 0.67%. The company has a P/E ratio of 15.2. Currently, there is 1 analyst who rates American Equity Investment Life a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AEL - FREE

TheStreet Quant Ratings rates American Equity Investment Life as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full American Equity Investment Life Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null